RAMM Pharma Corp.
RAMM
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 573.60K | 382.50K | 539.40K | 332.00K | 584.20K |
| Total Receivables | 625.90K | 1.13M | 1.16M | 1.20M | 1.18M |
| Inventory | 661.20K | 1.15M | 1.41M | 1.39M | 1.82M |
| Prepaid Expenses | 19.60K | 12.60K | 12.30K | 12.40K | 185.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.20K | 52.30K | 57.60K | 145.40K | 73.00K |
| Total Current Assets | 1.88M | 2.72M | 3.18M | 3.08M | 3.85M |
|
|
|||||
| Total Current Assets | 1.88M | 2.72M | 3.18M | 3.08M | 3.85M |
| Net Property, Plant & Equipment | 4.73M | 8.07M | 8.06M | 7.59M | 8.04M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.80K | 3.20K | 22.70K | 75.80K | 134.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.61M | 10.79M | 11.25M | 10.74M | 12.02M |
|
|
|||||
| Total Accounts Payable | 271.60K | 354.50K | 492.50K | 539.10K | 462.40K |
| Total Accrued Expenses | 199.40K | 146.10K | 146.90K | 143.30K | 257.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 49.20K | 20.10K | 31.30K | 84.00K | 74.30K |
| Total Finance Division Other Current Liabilities | 2.02M | 1.31M | 1.37M | 1.34M | 1.38M |
| Total Other Current Liabilities | 2.02M | 1.31M | 1.37M | 1.34M | 1.38M |
| Total Current Liabilities | 2.54M | 1.83M | 2.04M | 2.10M | 2.17M |
|
|
|||||
| Total Current Liabilities | 2.54M | 1.83M | 2.04M | 2.10M | 2.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.20K | -- | -- | 52.60K | 60.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.55M | 1.83M | 2.04M | 2.16M | 2.23M |
|
|
|||||
| Common Stock & APIC | 48.64M | 49.10M | 49.17M | 46.88M | 48.69M |
| Retained Earnings | -53.39M | -48.89M | -48.59M | -46.25M | -47.30M |
| Treasury Stock & Other | 8.82M | 8.76M | 8.63M | 7.95M | 8.39M |
| Total Common Equity | 4.07M | 8.96M | 9.22M | 8.59M | 9.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.07M | 8.96M | 9.22M | 8.59M | 9.78M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.07M | 8.96M | 9.22M | 8.59M | 9.78M |
|
|
|||||